SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001178913-17-000962
Filing Date
2017-03-29
Accepted
2017-03-29 16:13:45
Documents
3
Period of Report
2017-03-29
Filing Date Changed
2017-03-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zk1719762.htm 8-K 22339
2 EXHIBIT 3.1 exhibit_3-1.htm EX-3.1 74540
3 EXHIBIT 3.2 exhibit_3-2.htm EX-3.2 84090
  Complete submission text file 0001178913-17-000962.txt   182541
Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 31905
Business Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 31905 972-74-710-7171
PLURISTEM THERAPEUTICS INC (Filer) CIK: 0001158780 (see all company filings)

IRS No.: 980351734 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-31392 | Film No.: 17722370
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1